Unexpected high rate of early tumor recurrence in patients with HCV-related HCC undergoing interferon-free therapy.

@article{Reig2016UnexpectedHR,
  title={Unexpected high rate of early tumor recurrence in patients with HCV-related HCC undergoing interferon-free therapy.},
  author={Mar{\'i}a Elisa Reig and Zoe Mari{\~n}o and Christie Perell{\'o} and Mercedes I{\~n}arrairaegui and Andrea Ribeiro and Sabela Lens and Alba D{\'i}az and Ram{\'o}n Vilana and Anna Darnell and Maria Varela and Bruno Sangro and Jos{\'e} Lu{\'i}s Calleja and Xavier Forns and Jordi Bruix},
  journal={Journal of hepatology},
  year={2016},
  volume={65 4},
  pages={
          719-726
        }
}
BACKGROUND & AIMS The success of direct-acting antivirals (DAA) against hepatitis C is a major breakthrough in hepatology. Until now, however, there are very few data on the effect of hepatitis C virus (HCV) eradication in patients who have already developed hepatocellular carcinoma. METHODS The study included patients with HCV infection and prior history of treated hepatocellular carcinoma who achieved complete response and lacked 'non-characterized nodules' at the time they underwent anti… CONTINUE READING
Related Discussions
This paper has been referenced on Twitter 59 times. VIEW TWEETS

Citations

Publications citing this paper.
Showing 1-10 of 163 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 30 references

Targeting metastasis

Nature Reviews Cancer • 2016

Unexpected early tumor recurrence in patients with hepatitis C virus -related hepatocellular carcinoma undergoing interferon-free therapy: a note

M. Reig, Z. Mariño, +11 authors J. Bruix
2016

Similar Papers

Loading similar papers…